SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-035449
Filing Date
2023-12-28
Accepted
2023-12-27 20:25:09
Documents
15
Period of Report
2023-12-27
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20231227_8k.htm   iXBRL 8-K 46165
2 EXHIBIT 99.1 ex_610312.htm EX-99.1 13668
7 image01.jpg GRAPHIC 7290
  Complete submission text file 0001437749-23-035449.txt   227823

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20231227.xsd EX-101.SCH 3893
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20231227_def.xml EX-101.DEF 13445
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20231227_lab.xml EX-101.LAB 17672
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20231227_pre.xml EX-101.PRE 13422
9 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20231227_8k_htm.xml XML 4397
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 231519183
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)